Rates of undetectable HCV-RNA at week @ ( complete early virologic response -LSB- cEVR -RSB- ; primary end point ) were significantly higher in GT@ ,@ patients receiving Lambda vs. alfa ( @/@ , @ % vs. @/@ , @ % ) ; with similar cEVR rates for GT@ ,@ ( @/@ , @ % vs. @/@ , @ % ) .